Zhejiang Conba Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Conba Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Guizhou Xinbang Pharmaceutical Company Limited
sales of 6.58 billion Chinese Renmimbi [US$936.83 million]
of which 64%
was Pharmaceutical industry),
Zhejiang Medicine Co., Ltd.
(6.86 billion Chinese Renmimbi [US$976.48 million]
of which 71%
was Domestic), and
KPC Pharmaceuticals Inc
(7.10 billion Chinese Renmimbi [US$1.01 billion]
of which 39%
was Drugs Wholesale and Retail).
Zhejiang Conba Pharmaceutical Co., Ltd. reported sales of 6.78 billion Chinese Renmimbi (US$965.98 million)
December of 2018.
increase of 28.2%
versus 2017, when the company's sales were 5.29 billion Chinese Renmimbi.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
93.6% in 2018, from
13.06 million Chinese Renmimbi to 25.28 million Chinese Renmimbi.
Not all segments of Zhejiang Conba Pharmaceutical Co., Ltd. experienced an increase in sales in 2018:
sales of Commerce fell 60.2% to 83.77 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).